This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A final look at the use of preventative hereditary angioedema(HAE) treatments such as Haegarda, Orladeyo, and Takhzyro, as well as the potential of Donidalorsen in HAE.

Ticker(s): BCRX, IONS, TAK, CSLLY

Who's the expert?

 

  • Allergy and Immunology Specialist at Olean Medical Group.
  • Currently manages 12 patients with Hereditary Angioedema.
  • Familiar with Phase 3 KONFIDENT Trial regarding Sebetralstat.

Interview Goal
see title.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.